A patient on chlorpropamide for diabetes experienced severe weakness and fainting. Testing confirmed chlorpropamide-induced hemolytic anemia, which resolved after discontinuing the medication.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: